The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Novartis AG

NYSE: NVS
Last

(U.S.) $94.55

Today's change-0.81 -0.85%
Updated September 4 4:01 PM EDT. Delayed by at least 15 minutes.
 

Novartis AG

NYSE: NVS
Last

(U.S.) $94.55

Today's change-0.81 -0.85%
Updated September 4 4:01 PM EDT. Delayed by at least 15 minutes.

Novartis AG down (U.S.)$0.81

Novartis AG closed lower Friday, dropping (U.S.)$0.81 or 0.85% to (U.S.)$94.55. Shares have lost 3.86% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 5.13% during the last year.

Key company metrics

  • Open(U.S.) $94.57
  • Previous close(U.S.) $95.36
  • High(U.S.) $95.01
  • Low(U.S.) $93.81
  • Bid / Ask-- / --
  • YTD % change+2.04%
  • Volume2,265,352
  • Average volume (10-day)2,890,771
  • Average volume (1-month)1,940,898
  • Average volume (3-month)1,924,923
  • 52-week range(U.S.) $84.17 to (U.S.) $106.84
  • Beta0.64
  • Trailing P/E23.91×
  • P/E 1 year forward18.37×
  • Forward PEG2.57×
  • Indicated annual dividend(U.S.) $2.67
  • Dividend yield2.82%
  • Trailing EPS(U.S.) $3.95
Updated September 4 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.77%

Based on its net profit margin of 18.77%, Novartis AG is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.87%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue12,89612,20213,35413,300
Total other revenue--------
Total revenue12,89612,20213,35413,300
Gross profit8,4098,2228,9388,879
Total cost of revenue4,4873,9804,4164,421
Total operating expense10,6159,41711,00310,561
Selling / general / administrative3,6173,2823,9653,565
Research & development2,2062,0672,5372,161
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total3058885414
Operating income2,2812,7852,3512,739
Interest income (expense), net non-operating-164-179-188-182
Gain (loss) on sale of assets--------
Other--------
Income before tax2,1562,6782,7563,532
Income after tax1,8562,3062,4483,102
Income tax, total300372308430
Net income1,83613,0051,4913,223
Total adjustments to net income--------
Net income before extra. items1,8542,3062,4523,085
Minority interest-204-17
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,8542,3062,4523,085
Inc. avail. to common incl. extra. items1,83613,0051,4913,223
Diluted net income1,83613,0131,4913,223
Dilution adjustment--800
Diluted weighted average shares2,4482,4462,4582,460
Diluted EPS excluding extraordinary itemsvalue per share0.760.951.001.25
Dividends per sharevalue per share0.000.002.760.00
Diluted normalized EPSvalue per share0.870.981.061.36